I wanted to let you know that after much consideration and reflection I am retiring from my position as Executive Director of the Clinical Trials Transformation Initiative by the end of 2023.
My time at CTTI has been incredibly rewarding both professionally and personally and my decision to retire was not an easy one. I am grateful for the support, opportunities, and camaraderie I have experienced throughout my time here. As I prepare to embark on a new chapter after five decades in healthcare, I feel a mixture of emotions, including excitement, as I contemplate the future for me and my loved ones.
When I arrived at CTTI in October of 2021, we were navigating our way into a post pandemic world and changing clinical trial ecosystem. Our CTTI team and members stepped up to meet these challenges and opportunities with creativity, curiosity, and resilience. It has been a privilege to work alongside this talented team and the many dedicated professionals, patients, and caregivers from across our membership who demonstrate their commitment to CTTI’s mission and bold vision each day.
Over the next several months, I am committed to ensuring a smooth transition of my responsibilities to my successor. I’m working closely with Duke and CTTI’s Executive Committee leadership – Chair Mark McClellan, Duke Co-chair John Alexander, and FDA Co-chair Khair ElZarrad – on a thoughtful and mindful succession plan that ensures the highest level of team and organizational integrity.
In addition, the CTTI team is actively involved in developing a transition process that includes their voices and reflects their perspectives about the next generation of leadership for our organization. The job posting for the Executive Director of CTTI has posted to Duke’s career webpage. I welcome any thoughts, ideas, and suggestions you wish to share as we begin this process.
And finally, I want to express my deepest gratitude to our CTTI community for making my experience with CTTI unforgettable. It gives me great pride to have been a part of CTTI’s work and achievements during my tenure. Our exciting and important work continues this fall and rest assured we won’t miss a beat with this transition.